The report will be delivered in 2-3 business days.

Prostate Cancer Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7220 | Format :


The prostate cancer drugs market consists of sales of various drugs used for the prevention and treatment of prostate cancer. Prostate cancer is one of the most common types of cancer caused due to uncontrollable development of cells in the prostate gland in men that produces the seminal fluid that nourishes and transports sperm. Some of the possible treatments for prostate cancer include hormonal therapy, chemotherapy, immunotherapy and targeted therapy.

The global prostate cancer drugs market was valued at about $7.6 billion in 2018 and is expected to grow to $10.38 billion at a CAGR of 8.1% through 2022.

North America was the largest region in the prostate cancer drugs market in 2016. This region is expected to remain the largest during the next five years. The prostate cancer drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

The increasing male geriatric population is a major driver for the prostate cancer drugs market. Prostate cancer is one of the most common types of cancer in men aged above 60. According to the United Nations (UN), there were around 962 million people aged 60 or above globally, accounting for 13% of the global population in 2017. The population aged 60 or above is also growing at a rate of around 3% per year. The American Cancer Society's statistics for prostate cancer in the USA states that about 6 prostate cancer cases in 10 are diagnosed in men aged 65 or above, and it is rare for men aged less than 40.

Recurrent/non-responsive prostate cancer is major restraint for the growth of the prostate cancer drugs market. This is because recurrent/non-responsive prostate cancer cells lead to recurrence or spread of the cancer after an initial treatment. Prostate cancer can recur locally in the tissue next to the prostate, the surrounding lymph nodes in the pelvis or lymph nodes outside this area, tissues next to the prostate (such as the muscles that help control urination, the rectum, or the wall of the pelvis). The cancer can also travel through the bloodstream and recur in bones or other organs. According to the American Society of Clinical Oncology (ASCO), around 50% to 95% of men in the US with high-risk prostate cancer experience recurrence after localized treatment.

The use of combination therapy to treat prostate cancer is an emerging trend in the market. This is mainly because in some cases of prostate cancer, monotherapy has not been effective for the patients. In this regard, companies in the prostate cancer drugs market are investing more in combination therapy for the treatment of prostate cancer. For example, in February 2018, Pfizer announced the results of its Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC), which show that the use of XTANDI® (enzalutamide) in combination with androgen deprivation therapy (ADT) significantly reduced the risk of developing metastases or death by 71% compared to using ADT alone. Similarly, other combination therapies such as a combination of radiation therapy and androgen deprivation therapy for men with recurrent prostate cancer, and using chemotherapy drug docetaxel (Taxotere) along with ADT are also being used to treat prostate cancer.

The prostate cancer drugs market in the USA is regulated by the FDA which is responsible for approval of new drugs and lays down regulations related to treatment of prostate cancer. In February 2018, the FDA approved Erleada (apalutamide) for the treatment of prostate cancer that has not spread (non-metastatic), but continues to grow despite treatment with hormone therapy (castration-resistant). This was the first case of FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, and more such approvals are expected to follow in the future. Hence, the regulatory scenario related to prostate cancer drugs will encourage more drug manufacturers to enter the market.

In October 2018, Novartis acquired Endocyte for $2.1 billion. This acquisition will help Novartis to develop expands its radiotherapy capabilities for the treatment of prostate cancer. Endocyte is a biopharmaceutical company involved in developing targeted therapies for the personalized treatment of cancer. It was founded in 1996 and headquartered in Indiana, the USA.

Major players in the market are Astellas Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bayer AG

    1. Executive Summary

    2. Prostate Cancer Drugs Market Characteristics

    3. Prostate Cancer Drugs Market Size And Growth

    3.1. Global Prostate Cancer Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Prostate Cancer Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Prostate Cancer Drugs Market Segmentation

    4.1. Global Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hormone Sensitive Prostate Cancer

    Hormone Refractory Prostate Cancer

    4.2. Global Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hormonal Therapy

    Chemotherapy  

    Immunotherapy

    Targeted Therapy  

    4.3. Global Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals

    Clinics

    Other

    5. Prostate Cancer Drugs Market Regional And Country Analysis

    5.1. Global Prostate Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Prostate Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Prostate Cancer Drugs Market  

    6.1. Asia-Pacific Prostate Cancer Drugs Market Overview  

    6.2. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.4. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Prostate Cancer Drugs Market  

    7.1. China Prostate Cancer Drugs Market Overview  

    7.2. China Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.4. China Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Prostate Cancer Drugs Market  

    8.1. India Prostate Cancer Drugs Market Overview  

    8.2. India Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.4. India Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Prostate Cancer Drugs Market  

    9.1. Japan Prostate Cancer Drugs Market Overview  

    9.2. Japan Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.4. Japan Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Prostate Cancer Drugs Market  

    10.1. Australia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.3. Australia Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Prostate Cancer Drugs Market  

    11.1. Indonesia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.3. Indonesia Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Prostate Cancer Drugs Market  

    12.1. South Korea Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.3. South Korea Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Prostate Cancer Drugs Market  

    13.1. Western Europe Prostate Cancer Drugs Market Overview

    13.2. Western Europe Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.4. Western Europe Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Prostate Cancer Drugs Market  

    14.1. UK Prostate Cancer Drugs Market Overview

    14.2. UK Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.4. UK Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Prostate Cancer Drugs Market  

    15.1. Germany Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.3. Germany Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Prostate Cancer Drugs Market  

    16.5. France Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.6. France Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.7. France Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Prostate Cancer Drugs Market  

    17.1. Eastern Europe Prostate Cancer Drugs Market Overview

    17.2. Eastern Europe Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.4. Eastern Europe Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Prostate Cancer Drugs Market  

    18.1. Russia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.3. Russia Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Prostate Cancer Drugs Market  

    19.1. North America Prostate Cancer Drugs Market Overview

    19.2. North America Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.4. North America Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Prostate Cancer Drugs Market  

    20.1. USA Prostate Cancer Drugs Market Overview

    20.2. USA Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.4. USA Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Prostate Cancer Drugs Market  

    21.1. South America Prostate Cancer Drugs Market Overview

    21.2. South America Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.4. South America Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Prostate Cancer Drugs Market  

    22.1. Brazil Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.3. Brazil Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Prostate Cancer Drugs Market  

    23.1. Middle East Prostate Cancer Drugs Market Overview

    23.2. Middle East Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.4. Middle East Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Prostate Cancer Drugs Market  

    24.1. Africa Prostate Cancer Drugs Market Overview

    24.2. Africa Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.4. Africa Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Prostate Cancer Drugs Market Competitive Landscape And Company Profiles

    25.1. Prostate Cancer Drugs Market Competitive Landscape

    25.2. Prostate Cancer Drugs Market Company Profiles

    25.2.1. Astellas  Inc.

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2.  AstraZeneca plc

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3.  Johnson & Johnson

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4.  Sanofi S.A

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5.  Bayer AG

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Prostate Cancer Drugs Market

    27. Prostate Cancer Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Prostate Cancer Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Prostate Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Prostate Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: India, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: India, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: India, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Japan, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Japan, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Japan, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Australia, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Australia, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Australia, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Indonesia, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Indonesia, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Indonesia, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: South Korea, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: South Korea, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: South Korea, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: Western Europe, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Western Europe, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Western Europe, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: UK, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: UK, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: UK, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: Germany, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: Germany, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: Germany, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: France, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: France, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: France, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Eastern Europe, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Russia, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Russia, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Russia, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: North America, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: North America, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 49: North America, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 50: USA, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 51: USA, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 52: USA, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 53: South America, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 54: South America, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 55: South America, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 56: Brazil, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 57: Brazil, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 58: Brazil, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 59: Middle East, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 60: Middle East, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 61: Middle East, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 62: Africa, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 63: Africa, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 64: Africa, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 65: Astellas  Inc. Financial Performance
  • Table 66:  AstraZeneca plc Financial Performance
  • Table 67:  Johnson & Johnson Financial Performance
  • Table 68:  Sanofi S.A Financial Performance
  • Table 69:  Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Prostate Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Prostate Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: India, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: India, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: India, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Japan, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Japan, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Japan, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Australia, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Australia, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Australia, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Indonesia, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: South Korea, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: South Korea, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: South Korea, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: Western Europe, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: UK, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: UK, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: UK, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: Germany, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: Germany, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: Germany, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: France, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: France, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: France, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Eastern Europe, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Russia, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Russia, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Russia, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: North America, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: North America, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 49: North America, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 50: USA, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 51: USA, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 52: USA, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 53: South America, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 54: South America, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 55: South America, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 56: Brazil, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 57: Brazil, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 58: Brazil, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 59: Middle East, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 60: Middle East, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 61: Middle East, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 62: Africa, Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 63: Africa, Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 64: Africa, Prostate Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 65: Astellas  Inc. Financial Performance
  • Figure 66:  AstraZeneca plc Financial Performance
  • Figure 67:  Johnson & Johnson Financial Performance
  • Figure 68:  Sanofi S.A Financial Performance
  • Figure 69:  Bayer AG Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)